Show
Sort by
-
- Conference Paper
- C1
- open access
Intact phase II AAS metabolites on GC-MS
-
DoCoLab's experience in peptide (MW>2 kDa) analysis
-
- Conference Paper
- C3
- open access
Analysis of non-hydrolyzed sulfated steroids by GC-MS
-
GC-QTOF-MS : towards a complete and open screening method
-
Two years' of experience in small peptide analysis using dilute and shoot methodology
-
Identification and confirmation of diuretics and masking agents in urine by turbulent flow online SPE LC-MS/MS for doping control
-
Chemical ionization GC-MS/MS : current developments
-
GC-CI-MS/MS analysis of anabolic androgenic steroids
-
Stability of the alternative steroid profile (ASP), part III : influence of ACTH and corticosteroids on alternative steroid profiles
-
Increasing the sensitivity of gas chromatography-triple quadrupole mass spectrometry by using chemical ionization
-
Metabolic study of a steroid product containing dimethazine using human liver microsomes and a chimeric mouse model
-
Studies on the minor metabolite 6a-hydroxy-androstenedione for doping control purposes and its contribution to the steroid profile
-
Phase I and phase II metabolism of synthetic cannabinoids, the Ghent strategy
-
In vitro and in vivo metabolism studies of a nutritional supplement containing methylstenbolone
-
- Conference Paper
- C1
- open access
Influence on the alternative steroid profile, part I
-
Profiling of urinary formestane and confirmation by isotope ratio mass spectrometry
-
- Conference Paper
- C3
- open access
Fast quantification of THCA using microwave-accelerated derivatization and GC-MS/MS analysis
-
Improvements in GC-QqQ-MS screening, 1 year of experience
-
Summary of the Alternative Steroid Profiling WADA project
-
Development of a sensitive GC-C-IRMS method for the analysis of androgens
-
Development and validation of a UHPLC-tandem mass spectrometric method for the direct detection of formoterol in human urine
-
Matrix effects marker for multianalyte analysis of glucocorticoids and diuretics by LC-MS/MS in biological samples
-
Metabolic study of prostanozol using human liver licrosomes and humanized mice
-
Application of UHPLC-Orbitrap based mass spectrometry with scan-to-scan polarity switching for the direct detection of doping agents in urine
-
Doping control analysis of desmopressin in human plasma and urine by HPLC-ESI-MS/MS
-
Characterization and identification of a C-terminal amidated mechano growth factor (MGF) analogue in black market products
-
Validation of a steroidomic model and its application in doping control
-
- Conference Paper
- C1
- open access
How we risk: liposomes and steroids
-
- Conference Paper
- C1
- open access
Mibolerone metabolism in the uPA+/+-SCID chimeric mice
-
- Conference Paper
- C1
- open access
Statistical discrimination of steroid profiles: introduction of steroidomics in doping analysis
-
- Conference Paper
- C3
- open access
Application of size exclusion chromatography and time-of-flight mass spectrometry to screening of polysaccharide-based plasma expanders
-
- Conference Paper
- C1
- open access
Is a simple detection approach possible for desmopressin?
-
- Conference Paper
- C1
- open access
Excretation studies with beta-2-agonists
-
- Conference Paper
- C1
- open access
Application of in vivo urinary steroid detection in uPA+/+-SCID chimeric mice
-
Results of several (small) research projects at DoCoLab in 2008
-
Results of several (small) research projects at DoCoLab in 2007
-
Stability studies of thiazide diuretics
-
Validation of the metabolism of steroids in uPA+/+-SCID mice with humanized liver
-
Direct quantification of steroid glucuronides by liquid chromatography tandem mass spectrometry
-
General guidelines for the CID fragmentation of 3-keto-anabolic steroids
-
Implementation of DRS in doping control
-
Excretion studies with corticosteroids
-
Excretion studies with a supplement containing 5a-androst-1-ene-3b,17b-diol
-
Excretion studies with 7-keto-dehydro-epiandrosterone
-
Excretion studies with Tribulus terrestris
-
Excretion studies with 4-androstene-3,17-dione